Rivastigmine Tartrate
- Product NDC
- 62135-903
- 11-digit product format
- 621350903
- Labeler code
- 62135
- Product ID
- 62135-903_070bd281-9772-c587-e063-6294a90a04a2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine Tartrate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA207797
- Marketing category
- ANDA
- Marketing start
- 2017-09-28
- Substance
- RIVASTIGMINE TARTRATE
- Active strength
- 6 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rivastigmine Tartrate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIVASTIGMINE TARTRATE | 6 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9IY2357JPE |
| Rxcui | 312835, 312836, 314214, 314215 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-903-60 | Rivastigmine Tartrate | 60 in 1 BOTTLE | CAPSULE | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-903 | RIVASTIGMINE TARTRATE CAPSULE [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20231007_2bb5e0d6-f677-4021-9888-3ff90979ef7d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-903-60 | 62135090360 | 60 CAPSULE in 1 BOTTLE (62135-903-60) | 60 capsule | 2023-01-04 | No | No | Historical |